R Squared LTD Ardelyx, Inc. Transaction History
R Squared LTD
- $214 Billion
- Q4 2025
A detailed history of R Squared LTD transactions in Ardelyx, Inc. stock. As of the latest transaction made, R Squared LTD holds 10,788 shares of ARDX stock, worth $63,325. This represents 0.03% of its overall portfolio holdings.
Number of Shares
10,788
Previous 11,340
4.87%
Holding current value
$63,325
Previous $62.5 Million
0.66%
% of portfolio
0.03%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding ARDX
# of Institutions
246Shares Held
161MCall Options Held
697KPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA19MShares$111 Million0.0% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$103 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X013.8MShares$81.1 Million0.04% of portfolio
-
Macquarie Group LTD Australia, C310.5MShares$61.4 Million0.07% of portfolio
-
State Street Corp Boston, MA9.72MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $908M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...